Parliament Workbench
Data: Motions & questions to 19 Nov 2026 · Votes to 12 Nov 2026

Members' Business Motion · S2M-00667 · Session 2

Photodynamic Therapy for the Treatment of Wet Age-Related Macular Degeneration (AMD)

Lodged by Kate Maclean Lab Lodged 26 Nov 2003 Debate 4 Feb 2004 47 supporters

The motion

That the Parliament notes the recent decision by NHS Quality Improvement Scotland on the use of photodynamic therapy for the treatment of wet age-related macular degeneration (AMD) and acknowledges that photodynamic therapy is the only effective treatment for wet AMD, the most aggressive form of the disease and the leading cause of blindness in the UK, with around 650 new patients diagnosed with wet AMD in Scotland every year; is deeply concerned that funding has not been made available for clinicians to treat on the NHS those patients who urgently require the therapy, and endorses the demand by the Royal National Institute of the Blind Scotland and the Macular Disease Society that the Scottish Executive ensures that funding is immediately provided by all NHS boards, thereby saving the sight of those who could benefit from the therapy.

Signatures by party

47 MSPs besides the lodger · 31 from other parties
Lab 16SNP 11Con 6Green 5LD 3SSP 3Ind 2SSCUP 1

Party on the day each MSP signed. Signing a motion is voluntary and not whipped. Who signs whose motions

Vote

No recorded vote on this motion. Most motions are never debated, and many that are debated are agreed without a division. Vote records are published from 2011.

Supporters

47 MSPs

Lab 16 SNP 11 Con 6 Green 5 LD 3 SSP 3 Ind 1 Ind 1 SSCUP 1

Show all 47 supporters by party

Lab 16

SNP 11

Con 6

Green 5

LD 3

SSP 3

Ind 1

Ind 1

SSCUP 1

Party shown is each supporter’s party when the motion was published.

In the Official Report

No contribution in the Official Report cites S2M-00667 by reference.